Journal
LIFE-BASEL
Volume 12, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/life12050665
Keywords
cholangiocarcinoma; hepatocellularcarcinoma; immunotherapy; immune checkpoint inhibitors; immunoresistance; tumor microenvironment
Categories
Ask authors/readers for more resources
HCC and CCA are highly malignant forms of primary liver cancers. Carcinogenesis of hepatocellular and bile duct is a complex process influenced by genetic and epigenetic alterations, environmental factors, and the gut microbiome. Recent studies have identified the crucial role of intestinal microbiota in the pathogenesis and opened new possibilities for novel therapeutic strategies such as immunotherapy, improving the overall survival of cancer patients.
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) constitute highly malignant forms of primary liver cancers. Hepatocellular and bile duct carcinogenesis is a multiplex process, caused by various genetic and epigenetic alterations, the influence of environmental factors, as well as the implication of the gut microbiome, which was undervalued in the previous years. The molecular and immunological analysis of the above malignancies, as well as the identification of the crucial role of intestinal microbiota for hepatic and biliary pathogenesis, opened the horizon for novel therapeutic strategies, such as immunotherapy, and enhanced the overall survival of cancer patients. Some of the immunotherapy strategies that are either clinically applied or under pre-clinical studies include monoclonal antibodies, immune checkpoint blockade, cancer vaccines, as well as the utilization of oncolytic viral vectors and Chimeric antigen, receptor-engineered T (CAR-T) cell therapy. In this current review, we will shed light on the recent therapeutic modalities for the above primary liver cancers, as well as on the methods for the enhancement and optimization of anti-tumor immunity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available